| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |